FDA NDC

Genvoya

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
61958-1901
Proprietary name
Genvoya
Nonproprietary name
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
Labeler
Gilead Sciences, Inc.
Dosage form
TABLET
Strength
150 mg/1

Run it in Rivvi

Which 2027 plans near you dropped or restricted elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.